Institutional Ownership Avidity Biosciences, Inc. (RNA)
This table provides information about the institutional ownership of Avidity Biosciences, Inc. (RNA). We have compiled data on the 253 institutions that hold shares in the stock, with a total of 110 Million shares, which have been reported (via 13F filing form) to have a value of $3.56 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Price T Rowe Associates Inc
Baltimore, MD |
May 14, 2025 Q1 2025 |
11,338,098
shares
|
$366 Million
0.04% of portfolio
|
Q1 2025
Added 2.67%
|
|
Wellington Management Group LLP
Boston, MA |
May 13, 2025 Q1 2025 |
9,684,556
shares
|
$313 Million
0.06% of portfolio
|
Q1 2025
New holding
|
|
Vanguard Group Inc
Valley Forge, PA |
May 09, 2025 Q1 2025 |
9,243,205
shares
|
$298 Million
0.01% of portfolio
|
Q1 2025
Reduced 2.0%
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
8,622,513
shares
|
$278 Million
0.01% of portfolio
|
Q2 2024
Added 39.84%
|
|
Rtw Investments, LP
New York, NY |
Feb 14, 2025 Q4 2024 |
7,932,870
shares
|
$256 Million
3.76% of portfolio
|
Q4 2024
Reduced 2.46%
|
|
Avoro Capital Advisors LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
7,500,000
shares
|
$242 Million
3.18% of portfolio
|
Q4 2024
Added 9.09%
|
|
Janus Henderson Group PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
7,053,010
shares
|
$228 Million
0.11% of portfolio
|
Q4 2024
Added 44.05%
|
|
Ra Capital Management, L.P.
Boston, MA |
Feb 14, 2025 Q4 2024 |
6,300,408
shares
|
$203 Million
2.97% of portfolio
|
Q3 2024
Added 16.67%
|
|
State Street Corp
Boston, MA |
Feb 14, 2025 Q4 2024 |
4,602,191
shares
|
$149 Million
0.01% of portfolio
|
Q4 2024
Reduced 2.21%
|
|
Geode Capital Management, LLC
Boston, MA |
May 13, 2025 Q1 2025 |
2,755,246
shares
|
$88.9 Million
0.01% of portfolio
|
Q1 2025
Reduced 1.86%
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Feb 14, 2025 Q4 2024 |
2,751,944
shares
|
$88.8 Million
0.15% of portfolio
|
Q4 2024
Reduced 10.63%
|
|
Casdin Capital, LLC
New York, NY |
Feb 14, 2025 Q4 2024 |
2,045,000
shares
|
$66 Million
5.12% of portfolio
|
Q4 2024
Reduced 1.91%
|
|
Polar Capital Holdings PLC
London, X0 |
Feb 14, 2025 Q4 2024 |
1,271,891
shares
|
$41.1 Million
0.23% of portfolio
|
Q4 2024
Reduced 17.52%
|
|
Driehaus Capital Management LLC
Chicago, IL |
Feb 14, 2025 Q4 2024 |
1,228,058
shares
|
$39.6 Million
0.35% of portfolio
|
Q4 2024
Added 40.84%
|
|
Morgan Stanley
New York, NY |
Feb 14, 2025 Q4 2024 |
1,213,776
shares
|
$39.2 Million
0.0% of portfolio
|
Q4 2024
Added 98.58%
|
|
Siren, L.L.C.
New York, NY |
Feb 14, 2025 Q4 2024 |
1,127,295
shares
|
$36.4 Million
1.45% of portfolio
|
Q4 2024
Reduced 21.76%
|
|
Orbimed Advisors LLC
San Diego, CA |
Feb 14, 2025 Q4 2024 |
1,112,886
shares
|
$35.9 Million
0.88% of portfolio
|
Q4 2024
Added 6.52%
|
|
Cormorant Asset Management, LP
Boston, MA |
Feb 14, 2025 Q4 2024 |
1,050,000
shares
|
$33.9 Million
2.41% of portfolio
|
Q3 2024
Added 147.06%
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
May 09, 2025 Q1 2025 |
1,023,578
shares
|
$33 Million
0.01% of portfolio
|
Q1 2025
Reduced 0.52%
|
|
Northern Trust Corp
Chicago, IL |
May 13, 2025 Q1 2025 |
1,018,482
shares
|
$32.9 Million
0.0% of portfolio
|
Q1 2025
Reduced 5.65%
|
|
Artisan Partners Limited Partnership
Milwaukee, WI |
May 14, 2025 Q1 2025 |
928,227
shares
|
$30 Million
0.05% of portfolio
|
Q1 2025
Reduced 8.57%
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
May 05, 2025 Q1 2025 |
873,222
shares
|
$28.2 Million
0.03% of portfolio
|
Q1 2025
Added 9.29%
|
|
Woodline Partners LP
San Francisco, CA |
Feb 14, 2025 Q4 2024 |
865,820
shares
|
$27.9 Million
0.19% of portfolio
|
Q4 2024
Added 27.67%
|
|
Goldman Sachs Group Inc
New York, NY |
May 09, 2025 Q1 2025 |
784,704
shares
|
$25.3 Million
0.0% of portfolio
|
Q1 2025
Added 2.84%
|
|
Fiera Capital Corp
Montreal, A8 |
May 07, 2025 Q1 2025 |
772,300
shares
|
$24.9 Million
0.09% of portfolio
|
Q1 2025
Added 92.51%
|